Published in Theranostics on April 13, 2011
Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol (2011) 2.24
Biomedical applications of graphene. Theranostics (2012) 1.67
Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater (2012) 1.56
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano (2013) 1.44
Biodegradable gold nanovesicles with an ultrastrong plasmonic coupling effect for photoacoustic imaging and photothermal therapy. Angew Chem Int Ed Engl (2013) 1.36
Graphene: a versatile nanoplatform for biomedical applications. Nanoscale (2012) 1.32
Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater (2013) 1.31
Pharmacokinetics, metabolism and toxicity of carbon nanotubes for biomedical purposes. Theranostics (2012) 1.30
The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics (2012) 1.22
Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials (2012) 1.17
HSA coated iron oxide nanoparticles as drug delivery vehicles for cancer therapy. Mol Pharm (2011) 1.11
Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging. Theranostics (2012) 1.11
Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat Protoc (2013) 1.10
Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett (2012) 1.02
Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials (2013) 1.00
Bioconjugated pluronic triblock-copolymer micelle-encapsulated quantum dots for targeted imaging of cancer: in vitro and in vivo studies. Theranostics (2012) 0.97
Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics (2014) 0.96
Reducing X-Ray Induced Oxidative Damages in Fibroblasts with Graphene Oxide. Nanomaterials (Basel) (2014) 0.96
Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy. Adv Mater (2014) 0.94
Phase and size controllable synthesis of NaYbF4 nanocrystals in oleic acid/ionic liquid two-phase system for targeted fluorescent imaging of gastric cancer. Theranostics (2013) 0.93
CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells. Theranostics (2015) 0.91
Can nanotechnology potentiate photodynamic therapy? Nanotechnol Rev (2012) 0.89
In vitro hematological and in vivo vasoactivity assessment of dextran functionalized graphene. Sci Rep (2013) 0.88
Biomimetic one-pot synthesis of gold nanoclusters/nanoparticles for targeted tumor cellular dual-modality imaging. Nanoscale Res Lett (2013) 0.88
Graphene-based contrast agents for photoacoustic and thermoacoustic tomography. Photoacoustics (2013) 0.88
Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis. Theranostics (2012) 0.88
Perspectives on the application of nanotechnology in photodynamic therapy for the treatment of melanoma. Nano Rev (2014) 0.87
Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug. Int J Nanomedicine (2014) 0.87
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer. Nanoscale Res Lett (2014) 0.87
VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle. Nanoscale (2013) 0.87
Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging. Theranostics (2011) 0.87
Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA. Sci Rep (2015) 0.84
Graphene as cancer theranostic tool: progress and future challenges. Theranostics (2015) 0.84
Graphene-based nanomaterials for bioimaging. Adv Drug Deliv Rev (2016) 0.82
Surface engineering of graphene-based nanomaterials for biomedical applications. Bioconjug Chem (2014) 0.82
Shining light on nanotechnology to help repair and regeneration. Biotechnol Adv (2012) 0.82
Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots. Sci Rep (2013) 0.82
Graphene-based nanovehicles for photodynamic medical therapy. Int J Nanomedicine (2015) 0.82
Identification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs. Theranostics (2014) 0.81
Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide. Biomaterials (2014) 0.81
Inhibitory effect of caffeic acid on ADP-induced thrombus formation and platelet activation involves mitogen-activated protein kinases. Sci Rep (2015) 0.80
Drug Carrier for Photodynamic Cancer Therapy. Int J Mol Sci (2015) 0.80
Surface Functionalization of Chemically Reduced Graphene Oxide for Targeted Photodynamic Therapy. J Biomed Nanotechnol (2015) 0.80
Chlorin e6 Prevents ADP-Induced Platelet Aggregation by Decreasing PI3K-Akt Phosphorylation and Promoting cAMP Production. Evid Based Complement Alternat Med (2013) 0.79
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer. Nanoscale Res Lett (2014) 0.79
VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. Biomaterials (2014) 0.79
RGD-conjugated silica-coated gold nanorods on the surface of carbon nanotubes for targeted photoacoustic imaging of gastric cancer. Nanoscale Res Lett (2014) 0.79
Recent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications. Theranostics (2016) 0.79
An aptamer-targeting photoresponsive drug delivery system using "off-on" graphene oxide wrapped mesoporous silica nanoparticles. Nanoscale (2015) 0.78
Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy. Int J Nanomedicine (2015) 0.78
Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy. Nanoscale Res Lett (2016) 0.78
Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. Nanoscale (2015) 0.78
Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells. Oncotarget (2016) 0.78
Biological interactions and safety of graphene materials. MRS Bull (2012) 0.77
Toxicology of graphene-based nanomaterials. Adv Drug Deliv Rev (2016) 0.77
Graphene-based platforms for cancer therapeutics. Ther Deliv (2016) 0.76
Carbon Nanomaterials Interfacing with Neurons: An In vivo Perspective. Front Neurosci (2016) 0.75
Graphene Oxide-Gallic Acid Nanodelivery System for Cancer Therapy. Nanoscale Res Lett (2016) 0.75
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev (2016) 0.75
Polymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity. Nanoscale Res Lett (2016) 0.75
Design of Tumor Acidity-Responsive Sheddable Nanoparticles for Fluorescence/Magnetic Resonance Imaging-Guided Photodynamic Therapy. Theranostics (2017) 0.75
ICG-conjugated Magnetic Graphene Oxide for Dual Photothermal and Photodynamic Therapy. RSC Adv (2016) 0.75
Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy. Int J Nanomedicine (2017) 0.75
Role of Nanodiamonds in Drug Delivery and Stem Cell Therapy. Iran J Biotechnol (2016) 0.75
Chemical methods for the production of graphenes. Nat Nanotechnol (2009) 6.24
Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem (1991) 4.82
PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc (2008) 4.11
Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett (2010) 3.59
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev (2010) 2.44
Activatable photosensitizers for imaging and therapy. Chem Rev (2010) 2.23
Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small (2010) 2.11
Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol (2008) 2.09
Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials (2011) 1.56
Graphene-based materials in electrochemistry. Chem Soc Rev (2010) 1.47
Carbon nanohorns as anticancer drug carriers. Mol Pharm (2005) 1.43
Photodynamic therapy with fullerenes. Photochem Photobiol Sci (2007) 1.32
Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res (2006) 1.27
Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc (2008) 1.23
Fabrication of ZnPc/protein nanohorns for double photodynamic and hyperthermic cancer phototherapy. Proc Natl Acad Sci U S A (2008) 1.15
Photodynamic therapy: a review. Drugs Aging (1999) 1.07
Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res (2001) 1.03
Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy. Nanotechnology (2009) 1.01
A method based on multi-sensor data fusion for fault detection of planetary gearboxes. Sensors (Basel) (2012) 7.11
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood (2006) 4.92
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol (2006) 4.68
Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation (2005) 3.83
Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res (2008) 3.11
Fault diagnosis of rotating machinery based on an adaptive ensemble empirical mode decomposition. Sensors (Basel) (2013) 2.96
Super-resolution fluorescence imaging of organelles in live cells with photoswitchable membrane probes. Proc Natl Acad Sci U S A (2012) 2.46
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol (2009) 2.38
SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res (2010) 2.20
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol (2007) 2.04
Structural role of countertransport revealed in Ca(2+) pump crystal structure in the absence of Ca(2+). Proc Natl Acad Sci U S A (2005) 2.02
Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr (2009) 1.94
Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg (2006) 1.85
An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J Bone Miner Res (2013) 1.85
Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ Cardiovasc Genet (2011) 1.73
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest (2013) 1.68
Tacholess envelope order analysis and its application to fault detection of rolling element bearings with varying speeds. Sensors (Basel) (2013) 1.67
China's international trade and air pollution in the United States. Proc Natl Acad Sci U S A (2014) 1.66
Predicting soil erosion for alternative land uses. J Environ Qual (2006) 1.58
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials (2011) 1.56
Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater (2012) 1.56
RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol Pharm (2010) 1.55
MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res (2013) 1.54
Sema3A regulates bone-mass accrual through sensory innervations. Nature (2013) 1.53
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. J Virol (2005) 1.52
Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials (2011) 1.50
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res (2007) 1.48
Reduction of graphene oxide via L-ascorbic acid. Chem Commun (Camb) (2009) 1.48
A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid (2010) 1.46
A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res (2006) 1.46
Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics (2012) 1.45
Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano (2013) 1.44
Inflammatory cytokine TSLP stimulates platelet secretion and potentiates platelet aggregation via a TSLPR-dependent PI3K/Akt signaling pathway. Cell Physiol Biochem (2015) 1.43
Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro (2006) 1.43
Acute kidney injury in a Chinese hospitalized population. Blood Purif (2010) 1.41
Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol (2008) 1.39
Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest (2009) 1.39
Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression. Psychiatry Res (2010) 1.38
Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol (2008) 1.33
Single continuous wave laser induced photodynamic/plasmonic photothermal therapy using photosensitizer-functionalized gold nanostars. Adv Mater (2013) 1.31
Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Kidney Int (2010) 1.30
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther (2002) 1.30
MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3. FEBS Lett (2012) 1.30
HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proc Natl Acad Sci U S A (2010) 1.26
Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy. J Allergy Clin Immunol (2010) 1.26
Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed Microdevices (2008) 1.24
Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim Biophys Acta (2006) 1.24
Early mixed farming of millet and rice 7800 years ago in the Middle Yellow River region, China. PLoS One (2012) 1.22
A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn (2013) 1.22
Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob Agents Chemother (2007) 1.19
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjects. AIDS Res Hum Retroviruses (2006) 1.19
Graphene oxide as a matrix for enzyme immobilization. Langmuir (2010) 1.18
Oxidative stress-induced JNK1/2 activation triggers proapoptotic signaling and apoptosis that leads to diabetic embryopathy. Diabetes (2012) 1.17
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol Ther (2011) 1.16
Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res (2007) 1.16
Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett (2011) 1.14
A resistive memory in semiconducting BiFeO₃ thin-film capacitors. Adv Mater (2011) 1.13
Ca2+ occlusion and gating function of Glu309 in the ADP-fluoroaluminate analog of the Ca2+-ATPase phosphoenzyme intermediate. J Biol Chem (2004) 1.13
A marine algicidal actinomycete and its active substance against the harmful algal bloom species Phaeocystis globosa. Appl Microbiol Biotechnol (2012) 1.12
Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings. J Hepatol (2013) 1.12
Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer (2009) 1.11
Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res (2005) 1.11
Use of a DNA microarray for simultaneous detection of antibiotic resistance genes among staphylococcal clinical isolates. J Clin Microbiol (2007) 1.11
c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy. Diabetes (2012) 1.09
Advances and prospect of nanotechnology in stem cells. Nanoscale Res Lett (2009) 1.09
miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer (2012) 1.08
Antioxidant activity and mechanism of Rhizoma Cimicifugae. Chem Cent J (2012) 1.08
Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. J Clin Microbiol (2010) 1.06
A miRNA binding site single-nucleotide polymorphism in the 3'-UTR region of the IL23R gene is associated with breast cancer. PLoS One (2012) 1.06
Triphase interface synthesis of plasmonic gold bellflowers as near-infrared light mediated acoustic and thermal theranostics. J Am Chem Soc (2014) 1.06
MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury. Int J Biol Sci (2011) 1.05
PES1 promotes breast cancer by differentially regulating ERα and ERβ. J Clin Invest (2012) 1.05
Maternal hyperglycemia activates an ASK1-FoxO3a-caspase 8 pathway that leads to embryonic neural tube defects. Sci Signal (2013) 1.04
Evidence for a crucial role played by oxygen vacancies in LaMnO3 resistive switching memories. Small (2012) 1.04
Changes in upper extremity position cause migration of peripherally inserted central catheters in neonates. Pediatrics (2002) 1.04
Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc (2014) 1.03
Regulating health claims on food labels using nutrient profiling: what will the proposed standard mean in the Australian supermarket? Public Health Nutr (2013) 1.03
A multifunctional ribonuclease-A-conjugated CdTe quantum dot cluster nanosystem for synchronous cancer imaging and therapy. Small (2010) 1.03
Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology (2009) 1.03
CaWRKY40, a WRKY protein of pepper, plays an important role in the regulation of tolerance to heat stress and resistance to Ralstonia solanacearum infection. Plant Cell Environ (2012) 1.02
Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol (2010) 1.02
Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett (2012) 1.02
A CCD-based reader combined quantum dots-labeled lateral flow strips for ultrasensitive quantitative detection of anti-HBs antibody. J Biomed Nanotechnol (2012) 1.02
Studies of Ca2+ ATPase (SERCA) inhibition. J Bioenerg Biomembr (2005) 1.01
HDAC inhibitors for the treatment of cutaneous T-cell lymphomas. Future Med Chem (2012) 1.01
DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivo Gastric Cancer Cells. Theranostics (2012) 1.01
Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small (2012) 1.01